Drugs & Side Effects | Cancer Drugs

Fosamax News

New Osteoporosis Drug, Forteo, No Better Than Fosamax

RSS News Feeds
Drugs & Pharmacuticals
Osteonecrosis of the Jaw (ONJ)
Fosamax
 All RSS Feeds

At a glance:

A government-funded study indicates that a new osteoporosis medication, Teriparatide (Forteo) works no better than alendronate (Fosamax) but is eight times more expensive. 
 
There may be patients for whom the new drug is indicated, for example, those with severe disease or who do not respond to standard treatment, but for most, the benefit does not justify the cost especially where resources are limited.

Pricey New Bone Drug Brings No Added Benefit

Forbes - 6/13/2006 9:29 AM

TUESDAY, June 13 (HealthDay News) -- A new drug to treat osteoporosis may be no more effective than existing drugs -- and cost eight times as much, a new study finds.
 
Teriparatide, sold under the brand name Forteo, did not provide better, more cost-effective results than the already commonly prescribed alendronate, sold under the brand name Fosamax, concludes a U.S. government-funded study conducted by researchers at the Stanford University School of Medicine
 
· Read The Full Fosamax Article From Forbes -->

· Read All Fosamax (Alendronate) News Stories -->

Comments On Fosamax News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: